Patel T, Ivo J, Pitre T, Faisal S, Antunes K, Kasumi O. An In-Home Medication Dispensing System to Support Medication Adherence for Patients With Chronic Conditions in the Community Setting: Prospective Observational Pilot Study. JMIR Form Res. 2022;6(5):e34906

​

Patel T, Ivo J, McDougall A, Lee C, Chang L, Carducci J, Pritchard S. Development of a Clinician Guide for Electronic Medication Adherence Products in Older Adults. Can Pharm J. 2022;155(2):119-127

​

Faisal S, Ivo J, Tennant R, Prior K, Grindrod K, McMillan C, Patel T. Integration of a smart multidose blister package for medication intake: A mixed method ethnographic informed study of older adults with chronic diseases. PLoS One.  2022;17(1):e0262012

​

Faisal S, Ivo J, McMillan C, Grindrod K, Patel T. In-home medication management by older adults: a modified ethnography study using digital photography walkabouts. Age Ageing. 2022;51(1):afab207

​

Faisal S. Lessons in reflexivity of a pharmacist conducting ethnography. Res Social Adm Pharm. 2021;17(10):1849-1855

​

Patel T. Medication nonadherence: Time for a proactive approach by pharmacists. Can Pharm J. 2021; 154(5):292-296

​

Faisal S, Ivo J, Patel T. A review of features and characteristics of smart adherence products. Can Pharm J. 2021;154(5):312-323

​

Lee C, Ivo J, Carter C, Faisal S, Shao YW, Patel T. Pharmacist interventions for persons with intellectual disabilities: A scoping review. Res Social Adm Pharm. 2021;17(2):257–72.

​

Patel T, McDougall A, Ivo J, Carducci J, Pritchard S, Chang F, et al. Development and content validation of an instrument to measure medication self-management in older adults. Pharmacy. 2021;9(2):78.

​

Faisal S, Ivo J, Tennant R, Prior KA, Grindrod K, McMillan C, Patel T. Implementation of a real-time medication intake monitoring technology intervention in community pharmacy settings: A mixed-method pilot study. Pharmacy. 2021;9(2):105

​

Chen M, Patel T, Chang F. The impact of a primary care, pharmacist-driven intervention in patients with chronic non-cancer pain—A pilot study. Pharmacy. 2020;8(3):113.

​

Faisal S, Ivo J, Lee C, Carter C, Patel T. The usability, acceptability, and functionality of smart oral multidose dispensing systems for medication adherence: A scoping review. J Pharm Pract. 2020;35(8).

​

Faisal S, Ivo J, McDougall A, Patel T. Stakeholder feedback of electronic medication adherence products: Qualitative analysis. J Med Internet Res. 2020;22(12).

​

Patel T, Grindrod KA. Antiseizure drugs and women: Challenges with contraception and pregnancy. Can Pharm J. 2020;153(6):357–60.

​

Patel T, Grindrod KA. Antiseizure drugs in women with epilepsy: Use before, during, and after pregnancy. Can Pharm J. 2020;66(4):266–9.

​

Patel T, Hasan S, Chang F, McFarlane T. Controlled substances in hospices after patient death: a cross-sectional survey of Ontario hospices. Int J Clin Pharm. 2020;42(5):1344–53.

 

Patel T, Ivo J, Faisal S, McDougall A, Carducci J, Pritchard S, et al. A prospective study of usability and workload of electronic medication adherence products by older adults, caregivers, and health care providers. J Med Internet Res. 2020;22(6).

 

Tabeefar H, Chang F, Cooke M, Patel T. Community pharmacists and chronic pain: A qualitative study of experience, perception, and challenges. Can J Pain. 2020;4(3):29–39.

​

Fernandez H, Cooke M, Patel T. Epilepsy and lifestyle behaviors related to bone health. Epilepsia. 2019;60(11):2306–13.

​

Fernandez H, Mohammed HT, Patel T. Vitamin D supplementation for bone health in adults with epilepsy: A systematic review. Epilepsia. 2018;59(4):885–96.

 

Foong A-L, Grindrod KA, Patel T, Kellar J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018;64(10):720–7.

 

Foong A-L, Patel T, Kellar J, Grindrod KA. The scoop on serotonin syndrome. Can Pharm J. 2018;151(4):233–9.

​

Lee L, Patel T, Molnar F, Seitz D. Optimizing medications in cognitively impaired older adults: considerations for primary care clinician. Can Fam Physician. 2018;64(9):646–52.

 

Cheng R, Yang Y, Chan M, Patel T. Medication incidents involving antiepileptic drugs in Canadian hospitals: A multi-incident analysis. Healthcare Q. 2017;20(2):54–62.

​

Duong S, Patel T, Chang F. Dementia: What pharmacists need to know. Can Pharm J. 2017;150(2):118–29.

​

Maximos M, Chang F, Patel T. Risk of falls associated with antiepileptic drug use in ambulatory elderly populations. Can Pharm J. 2017;150(2):101–11.

​

Patel T, Slonim K, Lee L. Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: A review of the literature. Can Pharm J. 2017;150(3):169–83.

​

Patel T, Chang F, Mohammed HT, Raman-Wilms L, Jurcic J, Khan A, et al. Knowledge, perceptions, and attitudes toward chronic pain and Its arrangement: A cross-sectional survey of frontline pharmacists in Ontario. PLOS One. 2016;11(6).

 

Patel T, Milligan J, Lee J. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic. J Spinal Cord Med. 2016;40(1):54–61.

​

Chang F, Patel T, Schulz ME. The “Rising Tide” of dementia in Canada: What does it mean for pharmacists and the people they care for? Can Pharm J. 2015;148(4):193–9.

​

Patel T, Chang F. Practice recommendations for Parkinson’s disease: Assessment and management by community pharmacists. Can Pharm J. 2015;148(3):142–9.

​

Patel T, Chang F. Parkinson’s disease guidelines for pharmacists. Can Pharm J. 2014;147(3):161–70.

​

Rojas-Fernandez CH, Patel T, Lee L. An interdisciplinary memory clinic: A novel practice setting for pharmacists in primary care. Ann Pharmacother. 2014;48(6):785–95.  

​

Seymour N, Patel T, Dixon H. Worsening of Myasthenia Gravis following the addition of Gabapentin for Essential Tremor. J Pharm Technol. 2013;29(4):191–3.

​

Patel T, Loewen PS. Should the window for intravenous administration of Tissue Plasminogen Activator in the treatment of Acute Ischemic Stroke be extended to 4.5 hours? Can J Hosp Pharm. 2009;62(3).

Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42(1):33–58.

​

Patel T, Radomski KM, Chandler MH. Assay Interaction between Oxaprozin and Phenytoin. Ann Pharmacother. 1997;31(2):254.